quinacrine has been researched along with Thrombocythemia, Essential in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Thrombocythemia, Essential: A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In ET, thrombosis was associated with JAK2V617F mutation (p < 0." | 1.40 | JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients. ( Almeida Santos, S; Bento, C; Caetano, G; Coucelo, M; Duarte, M; Fidalgo, T; Fortuna, M; Menezes, C; Ribeiro, ML; Sevivas, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coucelo, M | 1 |
| Caetano, G | 1 |
| Sevivas, T | 1 |
| Almeida Santos, S | 1 |
| Fidalgo, T | 1 |
| Bento, C | 1 |
| Fortuna, M | 1 |
| Duarte, M | 1 |
| Menezes, C | 1 |
| Ribeiro, ML | 1 |
1 other study available for quinacrine and Thrombocythemia, Essential
| Article | Year |
|---|---|
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Blood Platelets; Case-Control Studies; CD11b Antigen; Codon | 2014 |